KinexaTherapeutics ApS: Financial statements 2024
CVR: 43952633
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
KinexaTherapeutics ApS (CVR 43952633) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -276,347 and a net result of DKK -286,245. Equity in the 2024 report amounted to DKK -258,745.
- Gross Profit
- DKK -276,347
- Profit/Loss
- DKK -286,245
- Equity
- DKK -258,745
- Total Assets
- DKK 67,253
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
KinexaTherapeutics ApS has published its interim report for the period March 28, 2023 to December 31, 2023.
About KinexaTherapeutics ApS
KinexaTherapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rune Risgaard, Lars Jørgensen and Mikkel Bender. The company is owned by MEVA HOLDING ApS, CORIS Holding ApS and LAJOVI Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,726 and a net result of DKK -56,425 compared with DKK -286,245 the year before. Equity in the 2025 report amounted to DKK -315,170.